Home
Fulcrum Therapeutics

Fulcrum Therapeutics Market Share Analysis for August 2026

WE ARE RARE Fulcrum is a great place to have a career. Why? Because we have the FULcrew! Our people make us great. At Fulcrum, you can count on finding

Health > Biotechnology and Pharmaceuticals

Domainfulcrumtx.com

Year Founded2016

Employees51 - 200

Annual Revenue$25M - $50M

Fulcrum Therapeutics

Fulcrum Therapeutics (including company regionals)

fulcrumtx.com

See more website traffic and engagement information

Fulcrum Therapeutics Revenue up to August 2026 is 25M - 50M

revenue generated by Fulcrum Therapeutics top domains

Fulcrum Therapeutics top domains revenue over 3 years

Revenue for Fulcrum Therapeutics top domains

fulcrumtx.com25M - 50M

See more with Sales Intelligence

Total visits to Fulcrum Therapeutics's top domains

Understand Fulcrum Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

fulcrumtx.com9.4K

See more with Sales Intelligence

Avg. visit duration in Fulcrum Therapeutics's top domains

Analyze Fulcrum Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

fulcrumtx.com00:00:48

See more with Sales Intelligence

Avg. pageviews on Fulcrum Therapeutics's top domains

See how Fulcrum Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

fulcrumtx.com1.86

See more with Sales Intelligence

Fulcrum Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Fulcrum Therapeutics

These are the website technologies, by industry, used by Fulcrum Therapeutics top domains

Advertising (3)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Social (3)

Instagram

Widget (3)

Twemoji

More Technologies

9

See all

News & Signals from Fulcrum Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSlate Medicines merged with Fulcrum Therapeutics, Inc. on Aug 17th '26.Fulcrum Therapeutics, Inc. (NASDAQ: FULC)'s merger with Slate Medicines, Inc. Upon closing of the proposed transaction, Fulcrum shareholders are expected to own 5.0% of the combined company.

NewsSlate Digital Inc. merges with Fulcrum Therapeutics, Inc..Lilly to pay up to $370M for OmniAb collab; Slate, Fulcrum forge reverse merger.

NewsFulcrum Therapeutics, Inc. had issues with potential securities violations on Jun 1st '26.New York, New York-(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics" or the "Company") (NASDAQ: FULC).